AIMC Topic: Product Surveillance, Postmarketing

Clear Filters Showing 21 to 21 of 21 articles

Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning.

JAMA oncology
This study reports proof-of-principle early detection of chemotherapeutic-associated skin adverse drug reactions from social health networks using a deep learning–based signal generation pipeline to capture how patients describe cutaneous eruptions.